Obagi Medical to Bridgepoint

EV / LTM EBITDA

23.7x

EV / LTM Sales

2.8x

Enterprise Value

$460M

Primary Source

Company Release

All Observations

Source-specific multiples and notes for this transaction.

Primary?	Source Type	Fairness Opinion / Source	Advisor	Source Year	Enterprise Value	EV/Sales	EV/EBITDA	EV/Fwd EBITDA	Note	Citation
Primary	press release	Press Release	-	2026	$460M	2.8x	23.7x	-	15.1x 2024 EBITDA	Open